Head and neck cancer head and neck cancer, lymph node metastasis
Conditions
Interventions
puncture the targert metastatic lymph node guided under sonography and inject the anti-tumor agent adjusted for LDDS.
Sponsors
Katagiri Katsunori
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) diagnosed with head end neck cancer by histopathological or cytological examination and having lympn node metastases in the neck. 2) neck dissection is planned 3) aged 18 or older 4) written informed consent is obtained by patients themselves
Exclusion criteria
Exclusion criteria: 1) invasion of the cancer to the neck 2) alllergy to the drug used in this study 3) patients who are judged to be unsuitable for this study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequencies of the adverse events such as complication and allergic response before and after the injection procedure of anti-tumor agent prepared for LDDS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Histopathological evaluation of the treatment results for metastatic lymph nodes based on Oh-hoshi-Shimosato classification. | — |
Contacts
Public ContactKatsunori Katagiri
Iwate Medical University
Outcome results
None listed